社会经济不平等和心力衰竭发病率和死亡率:系统性审查和数据综合
Abdul Shakoor1, Willemijn A van Maarschalkerwaart1,2, Jeroen Schaap3,4
1Department of Cardiology, Cardiovascular Institute, Thorax Center, Erasmus MC, Rotterdam, The Netherlands.
ESC heart failure
|September 25, 2024
概括
社会经济地位 (SES) 影响心力衰竭 (HF) 发病率和患病率,但其与HF发病率和死亡率的联系是复杂的,并因指标而异. 承认SES差异有助于早期检测和量身定制的HF治疗.
科学领域:
- 心脏病学 心脏病学
- 公共卫生 公共卫生
- 健康差异 在健康上的差异
背景情况:
- 社会经济地位 (SES) 与心力衰竭 (HF) 发生率,患病率,发病率和死亡率有关.
- 关于SES-HF关系的现有数据不一致,需要进行全面的综合.
研究的目的:
- 系统地评估和综合SES和HF发病率和死亡率之间的关系.
- 分析不同的SES指标如何影响HF结果和治疗差异.
主要方法:
- 在六个数据库中进行系统的文献搜索,遵循PRISMA指南.
- 包括观察性研究报告HF发病率,流行率,住院,恶化HF (WHF),死亡率和治疗.
- 从单个和区域层面分析SES数据,使用单个和复合指标.
主要成果:
- 低SES与HF发病率 (72%) 和流行率 (75%) 的增加有关.
- 在45%的研究中,低SES显示死亡率增加,而在其他研究中,结果是混合的或不显著的.
- 对WHF,医疗治疗和先进的HF治疗利用观察到类似的模式;对于特定的SES指标和HF结果没有明确的模式.
结论:
- 社会经济差异影响HF发病率和管理,但与发病率和死亡率的关联并不是统一的预测.
- SES对HF结果的影响是复杂的,并且严重取决于所使用的具体指标.
- 将SES视为风险因素可以改善早期HF检测,治疗定制和公共卫生资源分配.
更多相关视频
相关概念视频
01:17Pathophysiology of Heart Failure
1.5K
Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
1.5K
01:26Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
396
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
396
01:26Imbalances in Cardiac Output
1.4K
The heart's primary function is to pump blood throughout the body, maintaining a balance between blood sent out (cardiac output) and blood returning (venous return). If this balance is disrupted, it can result in congestive heart failure (CHF), a severe condition where the heart becomes an inefficient pump, leading to inadequate blood circulation.
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send...
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send...
1.4K
01:22Heart Failure Drugs: Diuretics
349
Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
349
01:22Heart Failure Drugs: β-Blockers
320
β-adrenergic antagonists, commonly known as β-blockers, block the effects of sympathetic neurotransmitters such as noradrenaline (NA) and adrenaline (ADR). They have several beneficial effects in heart failure treatment. They reduce heart rate, the force of contraction, and cardiac muscle relaxation. They also slow the atrial-ventricular conduction rate and raise the threshold for arrhythmias. The concentration of β-blockers determines their effects on bronchodilation,...
320
01:26Heart Failure Drugs: Inotropic Agents
539
Positive inotropic agents are commonly used as the first line of treatment for heart failure. One such agent is digoxin, derived from the genus Digitalis, which has been known for centuries but effectively utilized since 1785. However, these cardiac glycosides can have potentially toxic effects due to their mechanism of action, which involves inhibiting Na+/K+-ATPase and increasing contractility. Digoxin is absorbed orally and distributed in various tissues, including the CNS. It has a long...
539